Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
Patients with type 2 diabetes who used a smartphone app for cognitive behavioral therapy showed a significant decrease in A1c levels.
Read Full NewsTransforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols
Not surprisingly, trust in government health agencies for cancer info has dipped
Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC
News, features, and commentary about cancer-related issues
Observational study shows greater microplastic burden in patients with lung malignancy
Health news and commentary gathered by MedPage Today staff
The health ramifications of the attack persist
1.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
2.
MRD-Guided Azacitidine May Delay Relapse in AML, MDS
3.
New Immune Therapy Boosts Disease Control in Prostate Cancer
4.
FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC
5.
A new therapeutic approach could help tackle radiation resistance in childhood brain tumors
1.
Exploring the Hope of New Treatments for Rhabdomyosarcoma
2.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
3.
Molecular Matching for Complex Blood Disorders
4.
Comprehensive Standards in Oncology for Modern Medicine
5.
Patient-Centric Approaches in Hematology: Integrating Individualized Care into Modern Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Innovations in Hematology
2.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
3.
Managing Fatigue During Cancer Treatment
4.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge